[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Pharmaceuticals Company Research Reports

Pharmaceuticals companies are involved into development, production as well as marketing of an extensive variety of medicines. The pharmaceuticals industry is represented by innumerable companies. Small biotechnology and biopharmaceutical manufacturers, mid-sized specialty companies, large multi-nationals enterprises are amid the world pharma companies.

Appearance of new products; introduction of new product costs structures and modes of healthcare delivery; modification of product cost, offerings and design; growing public scrutiny; scientific researches in the fields of nanotechnology, bioengineering, etc. are among trends contributing to changes in the pharmaceutical industry.

Johnson & Johnson, Pfizer, Inc., Roche Holding AG, Novartis International AG, Abbott Laboratories, etc. are amid behemoths of the pharmaceutical industry.

Within this MarketPublishers’ catalogue there are innumerable reports featuring pharmaceutical companies’ overviews. The research reports provide a state-of-the-art picture of the pharma market including the analyses of the pharmaceuticals companies. Evaluation of companies’ strategies and data on products offerings are available in the research studies.

Publications found: 3,987
Sort by:

Medicis Pharmaceutical Corp. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Medicis Pharmaceutical Corp. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Medicure Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Medicure Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Medigen Biotechnology Corp. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Medigen Biotechnology Corp. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

MediGene AG Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

MediGene AG Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Medinet Co. Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Medinet Co. Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Medipost Co Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Medipost Co Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 70 pages

Medirox AB Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Medirox AB Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Mediscience Planning Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Mediscience Planning Inc Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Medistem, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Medistem, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Medivation, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Medivation, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Medivir AB Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Medivir AB Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

MEDTOX Scientific Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

MEDTOX Scientific Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Medy-Tox Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Medy-Tox Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Meldex International Plc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Meldex International Plc Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Memphis Pharmaceuticals and Chemical Industries Company Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Memphis Pharmaceuticals and Chemical Industries Company Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Mera Pharmaceuticals Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Mera Pharmaceuticals Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Merck & Co. Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Merck & Co. Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 94 pages

Merck KGaA Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Merck KGaA Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Merck Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Merck Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Merrion Pharmaceuticals plc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Merrion Pharmaceuticals plc Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Mesoblast Limited Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Mesoblast Limited Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Metabolic Research, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Metabolic Research, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Metabolix, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Metabolix, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

MethylGene Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

MethylGene Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Metriopharm AG Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Metriopharm AG Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Mettler-Toledo International, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Mettler-Toledo International, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Microbix Biosystems Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Microbix Biosystems Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Microfluidics International Corporation. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Microfluidics International Corporation. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

MicroHoldings US, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

MicroHoldings US, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Micromet, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Micromet, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Midas Pharmasec Limited Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Midas Pharmasec Limited Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Migami, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Migami, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Millenia Hope Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Millenia Hope Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

MiMedx Group, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

MiMedx Group, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Minapharm Pharmaceuticals SAE Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Minapharm Pharmaceuticals SAE Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 75 pages

Miraculins Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Miraculins Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Miravant Medical Technologies Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Miravant Medical Technologies Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

MitoPharm Corp. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

MitoPharm Corp. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Mitsubishi Tanabe Pharma Corp. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Mitsubishi Tanabe Pharma Corp. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

MNI Nutraceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

MNI Nutraceuticals, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Mochida Pharmaceutical Co. Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Mochida Pharmaceutical Co. Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Molecular Pharmacology (USA) Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Molecular Pharmacology (USA) Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

MolMed S.p.A. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

MolMed S.p.A. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Mologen Holding AG Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Mologen Holding AG Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Momenta Pharmaceuticals Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Momenta Pharmaceuticals Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

RELIEF THERAPEUTICS Holding SA Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

RELIEF THERAPEUTICS Holding SA Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Moneylogix Group, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Moneylogix Group, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Monogram Energy, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Monogram Energy, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Morepen Laboratories Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Morepen Laboratories Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Morphosys AG Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Morphosys AG Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Filters

Search

Publishers

2,237
1,678
37
6
2
1
1
21
2
1
1

Regions

1,352
441
361
240
234
179
155
127
100
90
84
73
65
62
44
27
27
24
20
19
19
19
19
18
17
15
14
13
12
11
11
8
7
7
6
5
5
5
5
4
3
2
2
2
2
2
2
2
2
2
2
2
2
1
1
13

Price

Date

Pages

Offers